Brief: Opsens announces 510 clearance from U.S. FDA for Optomonitor II
26/09/2016 14:36
Sept 26 (Reuters) - Opsens Inc OPS.V
* Announces 510 clearance from U.S. Food and drug
Administration for Optomonitor II, a multimodality monitor
Source text for Eikon: ID:nCNWm8LPwa
Further company coverage: OPS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe